Alternative Name: | EGF, Urogastrone, URG |
|
MW: | ~6.3kDa |
|
Source: | Produced in E. coli. Non-glycosylated protein, containing 54 amino acids, with a molecular weight of 6.3 kDa. |
|
UniProt ID: | P07522 |
|
Formulation: | Lyophilized from 10mM Na2PO4, pH 7.5. Sterile filtered.
|
|
Purity: | ≥95% (HPLC, Reducing and Non-reducing SDS-PAGE, UV spectroscopy at 280 nm) |
|
Endotoxin Content: | ≤1 EU/μg protein measured by kinetic LAL analysis. |
|
Appearance: | White lyophilized (freeze-dried) powder. |
|
Biological Activity: | The activity is determined by the dose-dependent proliferation of mouse BALB/c 3T3 cells which is typically observed at concentations <0.1ng/ml. |
|
Reconstitution: | When reconstituting the product, gently pipet and wash down the sides of the vial to ensure full recovery of the protein into solution. It is recommended to reconstitute the lyophilized product with sterile water at a concentration of 0.1 mg/ml, which can be further diluted into other aqueous solutions. |
|
Shipping: | Ambient |
|
Long Term Storage: | -20°C |
|
Use/Stability: | It is recommended that a carrier protein (0.1% HSA or BSA) is added for long term storage. |
|
Handling: | Centrifuge the vial before opening the cap. After reconstitution, prepare aliquots and store at -20°C. |
|
Scientific Background: | Epidermal Growth Factor (EGF) is a growth factor that stimulates the proliferation of epithelial and epidermal cells. EGF family members are characterized by three intramolecular disulfide bonds and can bind to four different receptor tyrosine kinases known as EGFR/ErbB1, ErbB2, ErbB3, and ErbB4. |
|
Regulatory Status: | RUO - Research Use Only |
|